Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 936 results for "gsk"

GSK melanoma pill backed by UK cost watchdog with price cut

NICE fast-tracks GSK cancer pill recommendation

National Institute for Health and Care Excellence (NICE) has fast-tracked its recommendation for a third new drug for melanoma, from GlaxoSmithKline (GSK), after the pharma firm offered to supply it at a discounted price to the NHS. Tafinlar, ... Pharma Field, 13 hours ago

581 images for gsk

Reuters, 1 day ago
Reuters, 1 day ago
MinnPost, 5 days ago
Wall Street Pit, 6 days ago
Wall Street Pit, 6 days ago
Wall Street Pit, 6 days ago
Wall Street Pit, 6 days ago
Wall Street Pit, 6 days ago
International Business Times UK, 1 week ago
Bioscience Technology Online, 4 days ago

GlaxoSmithKline PLC (GSK) Showing Bearish Technicals With Support At $46.81

The patented option-trade picking algorithms that power's Artificial Intelligence Center Aare highlighting two trades on GlaxoSmithKline Plc ("GSK) today after it closed ...
 Individual.com10 hours ago Could GlaxoSmithKline Be A Better Investment Than Gilead?  Seeking Alpha1 day ago

Cut-price GSK skin cancer drug wins Nice approval

Tafinlar is used in aggressive forms of melanoma when the cancer cannot be removed surgically or has spread to other parts of the body A skin cancer drug developed by GlaxoSmithKline (Other OTC: GLAXF - news ) will be available through the NHS ...
 Yahoo! UK and Ireland19 hours ago GSK share price: UK healthcare watchdog backs group's melanoma drug  Invezz12 hours ago UK's NICE Wins Drug Price War With GSK  American Journal of Managed Care12 hours ago UK Regulator Recommends GSK's Skin Cancer Drug  Bidness Etc13 hours ago
Bioresearch Online

GSK Joins UKSouth African Effort to Target Non-communicable Diseases

By Casey McDonald. GSK will weigh in on non-communicable diseases (NCDs) in Africa with a £1m contribution and a commitment of internal R&D expertise supporting researchers from South African institutions, the company announced this month. ...
 Pharmaceutical Executive4 hours ago GSK in global alliance to tackle African diseases  Pharma Field6 days ago GSK joins with UK &South African Medical Research Councils to tackle NCDs in Africa  PharmaBiz1 week ago GSK And UK MRC Join Forces For NCD Research In Africa  Bioresearch Online1 week ago

GSK to make 10,000 doses of Ebola vaccine

The global pharmaceutical giant, GSK, is to manufacture ten thousand doses of its experimental Ebola vaccine following the commencement yesterday in the UK of human trials of the medicine the world is pinning its hopes on to contain an unprecedented ...
 Business Day Nigeria10 hours ago First UK volunteer gets experimental GSK Ebola shot in trial  London South East1 day ago First UK Volunteer Gets GSK Ebola Vaccine in Trial  Diabetes Care14 hours ago UPDATE 1-First UK volunteer gets experimental GSK Ebola shot in trial  Reuters1 day ago
American Banking News

Dr Reddy's-GSK pact runs into rough weather, review likely

Summary An agreement between GlaxoSmithKline Plc and Dr Reddy's Laboratories... An agreement between GlaxoSmithKline Plc and Dr Reddy's Laboratories (DRL) to develop and market select products across emerging markets outside India ...
 Financial Express1 day ago After Hours Most Active for Sep 17, 2014 : GSK, QQQ, BAC, PSX, KORS, SQNM, FOXA, INTC, PIR, RFMD, PLCM, MHK  Nasdaq1 day ago GlaxoSmithKline plc Earns Hold Rating from Deutsche Bank (GSK)  American Banking News1 day ago Deutsche Bank Reiterates Hold Rating for GlaxoSmithKline plc (GSK)  American Banking News1 day ago

Five Prime Therapeutics' Novel Target Licensed by Glaxo

Five Prime Therapeutics, Inc. ( FPRX ) announced that GlaxoSmithKline ( GSK ) has decided to exercise its option to gain an exclusive worldwide license to products containing an undisclosed muscle disease target developed by using Five Prime's ...
 Yahoo! Finance1 day ago

GSK On Track To Develop Safe And Tested Ebola Vaccine

The National Institute of Health (NIH) Director has said in a testimony to a US Senate panel that GlaxoSmithKline's Ebola vaccine has so far been safe in human trials. Meanwhile, Obama has called for greater global action to fight the epidemic ...
 Bidness Etc1 day ago Briton is first to try Ebola vaccine  Big News Network1 day ago

GlaxoSmithKline PLC (GSK) Trading Near $47.71 Resistance Level

TuesdayaEUR(TM)s trading in GlaxoSmithKline Plc ("GSK) gives options traders an opportunity for a 12.90% return. By selling the Nov. '14 $47.00 call and buying the Jan. '16 call at the $40.00 level ...
 Individual.com1 day ago

The FTSE 100′s Hottest Growth Stocks: GlaxoSmithKline plc

Today I am outlining why GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) could be considered a terrific stock for growth hunters. Pipeline pulling out the stops The business of drugs testing can never provide the prescription for guaranteed earnings ...
 Yahoo! UK and Ireland1 day ago The FTSE 100's Hottest Growth Stocks: GlaxoSmithKline plc  Motley Fool UK1 day ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less